Steady growth in prescription numbers.
We had the new R&D and partnerships announcement, so we are just waiting on the new product launch information - that was meant to be advised ‘in the interim’, i.e. before the 4C.
Maybe it will still come by the end of the month.
Ann: Quarterly Activities Report and Appendix 4C, page-2
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable